Screener Summaries Updates Institutions Sign In More Updates › Dividends & Buybacks › CRIS Dividends & Buybacks · Jun 25, 2026
Curis, Inc. stockholders approved an amendment to the Restated Certificate of Incorporation to effect a reverse stock… CRIS Curis Inc
Curis, Inc. stockholders approved an amendment to the Restated Certificate of Incorporation to effect a reverse stock split of common stock at a ratio between 1-for-5 and 1-for-25, as determined by the Board of Directors. Curis, Inc. is a biotechnology company focused on developing clinical-stage drug candidates for cancer.
More from Curis Inc Nasdaq notifies Curis of non-compliance with the $1.00 minimum bid price requirement Nov 6, 2026 Curis raises $8.5M in equity offering at $0.51 per share to fund CLL research Oct 19, 2026 Curis, Inc. received written notice from the Nasdaq Stock Market LLC on July 24, 2026, confirming that it has regained… Jul 30, 2026 Curis, Inc. implemented a 1-for-20 reverse stock split of its issued and outstanding common stock, effective July 2… Jul 2, 2026 Curis, Inc. announced that its reverse stock split is expected to become effective on July 2, 2026, at 5:00 PM ET Jul 1, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
